Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis
Human Leukocyte Antigen (HLA) variants can be a risk factor for developing potentially fatal drug hypersensitivity reactions. Our aim was to estimate the potential impact of genotyping for the HLA risk alleles incorporated in the Dutch Pharmacogenetics Working Group (DPWG) guidelines in The Netherla...
Gorde:
Egile Nagusiak: | Lisanne E. N. Manson (Egilea), Wilbert B. van den Hout (Egilea), Henk-Jan Guchelaar (Egilea) |
---|---|
Formatua: | Liburua |
Argitaratua: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak
-
Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
nork: Lisanne E. N. Manson, et al.
Argitaratua: (2020) -
Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions
nork: Lisanne E. N. Manson, et al.
Argitaratua: (2022) -
Distribution of HLA-B Alleles and Haplotypes in Qatari: Recommendation for Establishing Pharmacogenomic Markers Screening for Drug Hypersensitivity
nork: Mohammed Dashti, et al.
Argitaratua: (2022) -
Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
nork: Napatrupron Koomdee, et al.
Argitaratua: (2017) -
Association of HLA-B*5701 Genotypes and Abacavir-Induced Hypersensitivity Reaction: A Systematic Review and Meta-Analysis
nork: Wimonchat Tangamornsuksan, et al.
Argitaratua: (2015)